in New York City has announced a $28 million gift from longtime supporters Gertrude and Louis Feil through their to create a multidisciplinary neurological research institute.
The Feil Family Brain and Mind Research Institute will work to develop novel therapeutics for neurological diseases and conduct investigations designed to enhance current treatments and bridge the existing gap in translational medicine. Research will focus on neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, Lou Gehrig's disease (ALS), stroke, and vascular dementia. Brain developmental disorders, pain, addiction, and neuroimmunological diseases also will be investigated by researchers at the institute, which will be led by Constantino Iadecola, a leading neuroscientist in the fields of cerebrovascular diseases, stroke, and dementia.
In addition, the institute will work to recruit leaders in the neuroscience field and serve as a mentoring center for early-career faculty and mid-career clinical physician-scientists. To that end, the in New York City has awarded a $1.5 million grant for training and development.
"There is a rising tidal wave of age-related brain diseases striking our maturing population, especially the seventy-seven million baby boomers who will all need care for age-related brain diseases at the same time," said Iadecola. "Brain and mind diseases are a growing health challenge worldwide and a major contributor to loss of life and severe disability. By bridging the translational bench-to-bedside gap, the Feil Family Brain and Mind Research Institute promises to have a transformative impact on current care paradigms and change the landscape of neuroscience medicine."